Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
A review highlights the use of CD20 monoclonal antibody rituximab for treating diffuse alveolar hemorrhage in children. This study provides insights into the potential therapeutic applications of rituximab in this rare condition.
Read full storyGet the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.